Navigation Links
PBS-Bio works with 3 new firms to accelerate cancer drug development
Date:10/20/2010

hat UNBS1450 is very effective against various tumor types.

Unibioscreen CEO Christiane Verhaegen said the company wants to further decipher the mechanism of action of this novel drug candidate, in parallel with the ongoing clinical Phase I trial, to optimize the dose and schedule for the further development stages.

"This is a unique compound, that has shown to be very potent in pre-clinical tests. It is crucial for us to do the biomarker work with PBS-Bio, as this work helps us to get a more in-depth understanding of the mechanism and to define the most effective patient treatment," Verhaegen said.


'/>"/>

Contact: Dr. Edward Smith
edsmith@pbs-bio.com
602-418-9300
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Report: Discovery networks hostage-taking a rare terror event
2. University of Miami to host prestigious National Geographic Young Explorers Workshop, Sept. 25
3. IU receives $9.2 million from NSF to expand global networks and research
4. SRNL works to decrease hazards from mold in water damaged homes
5. Wildlife, virus zoonoses focus of workshop
6. Plastic antibody works in first tests in living animals
7. Moral issues raised by synthetic biology subject of Hastings Center workshop
8. AAPS presents therapeutic protein drug interactions workshop
9. Entertainment Studios Networks Names Janice Arouh President, Domestic Distribution and Marketing
10. Modeling reef ecosystems focus of workshop
11. Forest service co-hosts annual air pollution workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... PALM BEACH GARDENS, Fla. , June ... of multi-factor identity management and authentication solutions, today ... Altus strong, multi-factor authentication solution.  The ... ease of use of the DigitalPersona Altus ... and biometric reader compatibility. In ...
(Date:6/17/2015)... June 17, 2015  Synaptics Inc. (NASDAQ: ... today announced that Xiaomi, one of the world,s ... ClearPad ® family of capacitive touchscreen ... circuits (DDICs) for its latest smartphones, the Xiaomi ... for full in-cell display solutions and DDICs in ...
(Date:6/16/2015)... Sweden , June 16, 2015 ... from previously communicated that it will amount to at least ... MSEK. Due to the rapid increase in market growth and ... the previously communicated guidance that revenue for 2015 will exceed ... will amount to approximately 2,200 MSEK. Due to ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... Calif. -- The National Institutes for Health (NIH) have ... researchers to engineer an artificial pancreas system that will ... in behavior and physiology. This collaboration between physicians and ... 1 diabetes management human behavior, physiology, and medical ...
... Southern Research Station (SRS) today announced the publication of a ... native bark beetle that impacts both the economic and ecological ... Southern pine beetle is the most destructive forest pest ... in damage and lost timber income annually. The most recent ...
... of genetics, lifestyle and environment on breast cancer in ... of Louisville School of Public Health & Information Sciences ... Denkhoff. Through a SPHIS Department of Epidemiology ... grant from Susan G. Komen for the Cure, the ...
Cached Biology News:NIH awards group $4.5 million for smart artificial pancreas technology 2NIH awards group $4.5 million for smart artificial pancreas technology 3'Southern Pine Beetle II' 2UofL students seek answers to breast cancer disparities in minority populations 2UofL students seek answers to breast cancer disparities in minority populations 3
(Date:7/6/2015)... ... 2015 , ... Proove Biosciences , a commercial and ... Advisory Board meeting in Palm Springs, California. At the bi-annual meeting, the Medical ... new clinical practice and research ideas. The Board also discussed the development of ...
(Date:7/6/2015)... Tenn. , July 6, 2015 /PRNewswire/ ... entered into a definitive agreement to acquire ... and intervention platforms that combine data aggregation ... reporting capabilities to achieve actionable insights and ... will combine Altegra Health,s risk adjustment and ...
(Date:7/6/2015)... , June 29, 2015 ... has announced the addition of the "Biotechnology ... Biotechnology for the Non-Biotechnologist, ideal for ... theory, principles, techniques and potential of biotechnology. ... understand the basic theory, principles, techniques, and potential ...
(Date:7/6/2015)... PRINCETON, N.J. , July 6, 2015 Navitas, a leading ... Latin America hub in Bogota, Colombia ... advantage of the many benefits provided by Colombia , ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... location, allows US based clients to communicate with Navitas regulatory ...
Breaking Biology Technology:Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3
... Investigator Sites Now Available on goBalto.com , ... ... goBalto, an online drug development partnering site for the pharmaceutical ... is making its proprietary list of India-based Investigator Sites and ...
... - Completed Series B Total ... Opsona Therapeutics, a biotechnology company focused on novel therapeutic,and ... Roche Venture Fund and Enterprise Ireland have committed an,additional ... February,this year, bringing the total round to EUR21.3 million. ...
... May 18 Cell Therapeutics, Inc. (the "Company" or "CTI") ... its "Modified Dutch Auction" tender offer (the "Exchange Offer") to ... of its common stock, no par value (the "Common Stock"), ... principal amount of the following outstanding series of its convertible ...
Cached Biology Technology:goBalto Partners with Maya Clinicals to Expand Its List of Investigator Sites 2goBalto Partners with Maya Clinicals to Expand Its List of Investigator Sites 3Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 2Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 3Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 4Cell Therapeutics Amends 'Modified Dutch Auction' Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes 5
...
...
... sensitive and specific detection of microRNAs (miRNAs) ... have high binding affinity and discrimination, enabling ... Due to the high binding affinity of ... the amount of sample is needed compared ...
... Mixes are optimised for SYBR Green I assays ... Quantitative PCR, with the exception of template and ... optimal levels of active SYBR Green I dye ... reaction buffer that enables detection of low copy ...
Biology Products: